Arcadia Biosciences Inc

NASDAQ RKDA

Download Data

Arcadia Biosciences Inc Shareholders' Equity for the quarter ending March 31, 2024: USD 10.62 M

Arcadia Biosciences Inc Shareholders' Equity is USD 10.62 M for the quarter ending March 31, 2024, a -36.87% change year over year. Shareholders' Equity is the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Arcadia Biosciences Inc Shareholders' Equity for the quarter ending March 31, 2023 was USD 16.82 M, a -44.40% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the quarter ending March 31, 2022 was USD 30.26 M, a -32.00% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the quarter ending March 31, 2021 was USD 44.50 M, a 304.02% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the quarter ending March 31, 2020 was USD 11.02 M, a -14.05% change year over year.
NASDAQ: RKDA

Arcadia Biosciences Inc

CEO Ms. Pamela Haley
IPO Date May 15, 2015
Location United States
Headquarters 202 Cousteau Place, Davis, CA, United States, 95618
Employees 21
Sector Consumer Defensive
Industry Packaged foods
Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Similar companies

SENEA

Seneca Foods Corp A

NA

NA

BRID

Bridgford Foods Corporation

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email